Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial
Hovingh, G Kees, Dr, Kastelein, John J P, Prof, van Deventer, Sander J H, Prof, Round, Patrick, Ford, John, Saleheen, Danish, Rader, Daniel J, Prof, Brewer, H Bryan, Prof, Barter, Philip J, Prof
Published in The Lancet (British edition) (01.08.2015)
Published in The Lancet (British edition) (01.08.2015)
Get full text
Journal Article